Preliminary announcement | 29 July 2024 15:39 Epigenomics AG / Preliminary announcement on the disclosure of financial statements Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 29.07.2024 / 15:39 CET/CEST Preliminary announcement of the publication of financial reports according to […]
Year: 2024
29. July 2024
Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Read more
22. July 2024
Epigenomics AG: Preliminary half-year results as at June 30, 2024
Ad-hoc | 22 July 2024 17:49 Epigenomics AG / Schlagwort(e): Halbjahresergebnis Epigenomics AG: Vorläufiges Halbjahresergebnis zum 30. Juni 2024 22.07.2024 / 17:49 CET/CEST Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber […]
18. July 2024
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Gesamtstimmrechte | 10 April 2024 11:33 Epigenomics AG / Total Voting Rights Announcement Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 10.04.2024 / 11:33 CET/CEST Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG. The issuer […]
30. April 2024
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30.04.2024 / 15:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 Berlin (Germany), April 30, 2024 – Jens Ravens, Executive […]
10. April 2024
Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Gesamtstimmrechte | 10 April 2024 11:33 Epigenomics AG / Total Voting Rights Announcement Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 10.04.2024 / 11:33 CET/CEST Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG. The issuer […]
14. March 2024
Epigenomics AG publishes financial results for fiscal year 2023
EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual ReportEpigenomics AG publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2023 Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial […]